Pharma News, 2020

NICE has recommended use of Astellas' Xospata (gilteritinib) for adults with relapsed or refractory FLT3 mutation-positive acute myeloid leukaemia (AML).

AstraZeneca's Farxiga (dapagliflozin) has been granted a Fast Track Designation in the US for reducing the risk of hospitalisation for heart failure (hHF) or cardiovascular (CV...

GENEVA (Reuters) - The World Health Organization is forming a team of international experts to go to China to study the origins of the novel coronavirus, but it will not be in place before the...

DUBAI (Reuters) - Chinese state-owned pharmaceutical company Sinopharm has begun Phase III clinical trials of a COVID-19 vaccine in Abu Dhabi using up to 15,000 volunteers, the government in t...

On Wednesday, Elanco said its planned $7.

A US FDA advisory committee has voted in favour of approving Dublin, Ireland-based biopharma Mallinckrodt's terlipressin for Hepatorenal Syndrome Type 1 (HRS-1).

Teva Pharmaceuticals will serve as the defendant in a bellwether trial over an alleged industrywide scheme to fix generic drug prices, a Pennsylvania judge ruled July 13.

Johnson & Johnson Executive Committee Vice Chairman Dr.

Researchers have produced the first telomere to telomere (end-to-end) DNA sequence of a human chromosome.

BRUSSELS (Reuters) - Aspen (APNJ.

A study conducted by professor Yaakov Nahmias at Hebrew University in Israel has found that an existing cholesterol drug, fenofibrate, could ‘downgrade’ Covid-19 threat level to that of a common c...

In a new study, researchers have revealed details of the discovery of a new cancer drug that could be used to treat a range of cancer types, including some blood cancers and solid tumors.